Allison Rosen, MD, ScD, talks about using value-based insurance design as an incentive to improve type 2 diabetes outcomes.
Allison Rosen, MD, ScD, discusses the various patient and physician incentives that have been created to improve behavioral economics in diabetes. Dr. Rosen states that improving behavioral economics can be aimed toward patients by lower health insurance co-pays and toward physicians with a fee-for-service program.
Dr. Rosen says that in order to re-design health plans you have to identify patients with diabetes and able to target different incentives. For example, value-based insurance design (VBID) has recently had an uptake of programs that help reduce long-term complications and costs.
Exploring Pharmaceutical Innovations, Trust, and Access With CVS Health's CMO
July 11th 2024On this episode of Managed Care Cast, we're talking with the chief medical officer of CVS Health about recent pharmaceutical innovations, patient-provider relationships, and strategies to reduce drug costs.
Listen